Fenova Renal Research Adds to Roster
Frenova Renal Research, a division of Fresenius Medical Care North America (FMCNA) and the contract clinical research services provider dedicated exclusively to renal research, has added an additional location to its roster of manged clinical research sites. The new capacity will enhance Frenova's ability to help clinical research sponsors enroll patients rapidly and streamline clinical trials.
"We look forward to managing this site and working alongside our new partner investigators. Increasing our network of investigators and pool of patients allows our clients to significantly accelerate their clinical trials designed to ultimately better the lives of those living with renal disease," said Kurt Mussina, vice president, FMCNA, and general manager, Frenova Renal Research. "Between 2016 and 2018, we reduced the time from clinical trial agreement to first-patient-first-visit by over 80 percent among the sites we manage."
Frenova's approach to site management reduces administrative burdens, thereby compressing timelines. This provides investigators at sites managed by Frenova the opportunity to enroll patients sooner and with greater efficiency than they would otherwise.
The Las Vegas site of Nevada Kidney Disease and Hypertension Centers contributes 24 physicians, 2,000 ESRD patients, and 15,000 CKD patients to the program.
For more information visit www.FrenovaRenalResearch.com
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
